ABBOTT LABORATORIES (ABT) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$104.30

From 52W high−20.32%

Volume7.72M

Market cap$180.06B

P/E (TTM)33.5x

P/S (TTM)3.9x

Div yield2.42%

Key dataOct 19, 2026

Open

$104.30

From 52W high

−20.32%

Volume

7.72M

Market cap

$180.06B

ValuationView details →

P/E (Fwd)

17.5x

EV/EBITDA

18.3x

P/E (TTM)

33.5x

RSI (14)

55.0

MomentumView details →

1D Return

−0.79%

YTD Return

−17.09%

SummaryUpdated Jun 1, 2026

Abbott Laboratories (NYSE:ABT) is a diversified healthcare company founded in 1888 and headquartered in North Chicago, Illinois. Originally established as a pharmaceutical company by Dr. Wallace Calvin Abbott, the company has evolved over more than 135 years into one of the world's largest healthcare corporations. Abbott operates across four major business segments: Medical Devices, Diagnostics, Nutritional Products, and Established Pharmaceutical Products, serving patients and healthcare providers in over 160 countries worldwide.

Ask drillr about ABBOTT LABORATORIES →

ValuationView details →

P/E (Fwd)

17.5x

P/E (TTM)

33.5x

EV/EBITDA

18.3x

EV/Sales

4.5x

P/S (TTM)

3.9x

P/B (TTM)

3.5x

ProfitabilityView details →

Gross Margin

56.80%

Net Margin

11.65%

EBITDA Margin

24.31%

ROE (TTM)

10.61%

ROA (TTM)

4.97%

Asset Turnover

0.42x

GrowthView details →

Revenue YoY

+8.06%

EPS YoY

−61.41%

FCF YoY

+28.71%

Revenue CAGR 3Y

+0.51%

EPS CAGR 3Y

−1.72%

EBITDA YoY

−2.46%

MomentumView details →

1D Return

−0.79%

YTD Return

−17.09%

1Y Return

−19.79%

RSI (14)

55.0

vs 50D SMA

−1.81%

vs 200D SMA

+1.15%

Capital & dividendView details →

Debt/Equity

0.64x

Current Ratio

1.38x

Quick Ratio

0.97x

Div Yield

2.42%

Div Rate

$2.52

Div Growth 1Y

+6.78%

EarningsView details →

EPS (Actual)

$1.31

EPS Surprise

2.18%

Beats (12Q)

5/12

Next Q EPS Est

$1.64

Avg Surprise (4Q)

0.72%

Rev Surprise

0.85%

Financials snapshotView financials →

Revenue (TTM)

46.59B

Net Income (TTM)

5.42B

Op. CF (TTM)

9.90B

Next earningsOct 21, 2026 →

Latest newsMore news →

ABBOTT LABORATORIES is scheduled to release its third-quarter earnings report before the market opens on October 21, 2026.9h ago

ABBOTT LABORATORIES shares closed at $101.82, up 2.23% from the previous trading session.7d ago

Similar companies

T&L Co., Ltd.340570.KQ Sky Labs Inc.386380.KQ Value Added Technology Co., Ltd.043150.KQ Shinhung Co., Ltd004080.KS Vieworks Co., Ltd.100120.KQ Medtronic plcMDT Find similar companies →

Latest newsMore news →

ABBOTT LABORATORIES is scheduled to release its third-quarter earnings report before the market opens on October 21, 2026.9h ago ABBOTT LABORATORIES shares closed at $101.82, up 2.23% from the previous trading session.7d ago ABBOTT LABORATORIES introduced Ensure Max Protein 3-in-1 Muscle Support, a powder with 30 grams of protein, 5 grams of creatine monohydrate and 3 grams of calcium HMB per serving, available in chocolate and vanilla at major U.S. retailers.12d ago